SBH
ASTX

Segall Bryant & Hamill’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Segall Bryant & Hamill’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-800,962
Closed -$6.8M – 602
2013
Q3 		$6.8M Sell
800,962
-74,180
-8% -$469K 0.17% 170
2013
Q2 		$3.6M Buy
+875,142
New +$4.71M 0.09% 212

Segall Bryant & Hamill's ASTX Position: Q4 2013 in Review

Segall Bryant & Hamill sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 800,962 shares — an estimated $6.8M sold.

Segall Bryant & Hamill first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $6.8M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Segall Bryant & Hamill reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Segall Bryant & Hamill sold 800,962 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $6.8M.
  • Segall Bryant & Hamill first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Segall Bryant & Hamill's ASTEX PHARMACEUTICALS, INC COM position peaked at $6.8M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Segall Bryant & Hamill's 13F filing for Q4 2013, filed 5 Feb 2014.